Ledger.Open graph →
SEC Form D · filed April 21, 2011

Pulse Therapeutics, Inc

Offering
$2.0M
Sold
$1.3M
Exemption
—
Industry
Biotechnology
Location
ST. LOUIS, MO
Type
—

People & firms on this filing (15)

Daniel J. Broderick · St. Louis, MODirectorAmy L. Boyet · St. Louis, MOExecBevil J. Hogg · St. Louis, MODirectorStephen A. Wexler · St. Louis, MODirectorFrancis M. Creighton · St. Louis, MOExec · DirectorRogers Ritter · St. Louis, MOExecThomas J. Hillman · St. Louis, MODirectorMartin Hall · Cupertino, CAExec · DirectorAnn Winblad · Cupertino, CAExecDavid Liddle · Cupertino, CADirectorGail Ennis · Cupertino, CAExecDebby Meredith · Cupertino, CADirectorDaniel Moskowitz · Cupertino, CADirectorCorey S. Johnson · Nashville, TNDirectorPeter S. Finley · St. Louis, MOExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗